Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take: The main blood test used to check for high cholesterol is a lipid panel, also called a lipid profile. It usually measures or reports total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Depending on your health history and results, a clinician may also use non-HDL cholesterol, apolipoprotein B (ApoB), lipoprotein(a) or additional tests to better understand cardiovascular risk.
Most people do not need an exotic cholesterol test first. A standard lipid panel is the usual starting point. Advanced blood tests are helpful in selected situations, such as strong family history, very high LDL cholesterol, high triglycerides, diabetes, kidney disease, known cardiovascular disease or unclear risk after standard testing.
Common blood tests for high cholesterol
High cholesterol usually does not cause symptoms, so blood testing is the practical way to find it. The Centers for Disease Control and Prevention describes cholesterol testing as a simple blood draw that checks LDL cholesterol, HDL cholesterol, triglycerides and total cholesterol. The MedlinePlus cholesterol test guide uses similar terms and notes that a cholesterol test may also be called a lipid panel, lipid profile or lipoprotein panel.
| Test or result | What it tells you | Common use |
|---|---|---|
| Total cholesterol | The combined cholesterol content in major blood lipoproteins. | Broad screening number; less specific than LDL, non-HDL or ApoB. |
| LDL cholesterol (LDL-C) | Cholesterol carried by low-density lipoproteins, often called “bad” cholesterol. | Major focus for assessing and lowering atherosclerotic cardiovascular risk. |
| HDL cholesterol (HDL-C) | Cholesterol carried by high-density lipoproteins, often called “good” cholesterol. | Part of risk assessment; low HDL can add concern, especially with high triglycerides. |
| Triglycerides | A type of fat in the blood used for energy storage. | Helps identify metabolic risk and, when very high, pancreatitis risk. |
| Non-HDL cholesterol | Total cholesterol minus HDL cholesterol. | Captures cholesterol in LDL and other atherogenic particles; useful when triglycerides are elevated. |
| ApoB | A protein found on atherogenic particles; approximates particle number. | Used selectively when risk may be underestimated by LDL-C alone. |
| Lipoprotein(a), or Lp(a) | A mostly inherited cholesterol-related particle. | Often ordered once in adulthood or when family history or premature heart disease is a concern. |
The standard lipid panel
The lipid panel is the workhorse among blood tests for high cholesterol. It can be ordered during a preventive visit, during follow-up of known high cholesterol or after a cardiovascular event. It may be drawn from a vein at a laboratory or, in some settings, collected by fingerstick using a point-of-care device. A venous laboratory panel is generally preferred when decisions about medication, diagnosis of inherited lipid disorders or follow-up of very abnormal results are involved.
A standard report typically includes LDL-C, HDL-C, total cholesterol and triglycerides. LDL-C may be directly measured or estimated from the other lipid values. Estimation can be less reliable when triglycerides are very high, which is one reason a clinician may request repeat fasting testing or direct LDL measurement.
Total cholesterol
Total cholesterol is easy to understand but incomplete by itself. A total cholesterol result can be high because LDL-C is high, because HDL-C is high, because triglyceride-rich particles are increased or because of a combination of factors. For that reason, clinicians rarely make a full risk assessment from total cholesterol alone. It is useful as an entry point and as part of risk calculators, but the fractions matter.
LDL cholesterol
LDL-C is a central result because LDL particles can deposit cholesterol in artery walls and contribute to atherosclerotic plaque. The American Heart Association explains that high LDL cholesterol can contribute to fatty buildup in arteries and raise the risk of heart attack and stroke.
For many adults, a lower LDL-C is generally better, but the number that triggers treatment depends on overall risk. Someone with prior heart attack, stroke, diabetes, chronic kidney disease or very high inherited LDL may have a different target than someone with low short-term risk and no major risk enhancers. This is why a lipid panel is interpreted alongside blood pressure, age, sex, smoking status, diabetes status, kidney function, family history and sometimes imaging such as coronary artery calcium scoring.
HDL cholesterol
HDL-C is often called “good” cholesterol because higher HDL levels have historically been associated with lower cardiovascular risk. However, HDL is not a treatment target in the same simple way LDL is. A low HDL-C result can be a risk marker, especially when combined with high triglycerides, insulin resistance, smoking or excess abdominal weight. Raising HDL with medication has not consistently translated into better outcomes, so clinicians usually focus on evidence-based risk reduction: lowering LDL or non-HDL cholesterol when appropriate, improving triglycerides when elevated, stopping smoking, managing blood pressure, treating diabetes and increasing physical activity when safe.
Triglycerides
Triglycerides can rise after meals, with alcohol use, with high intake of refined carbohydrates, with uncontrolled diabetes, with hypothyroidism, kidney disease, certain medicines and some inherited conditions. Mild to moderate elevations often travel with metabolic risk. Very high levels raise concern for pancreatitis. The Endocrine Society lipid management guideline recommends pharmacologic treatment as an adjunct to diet and exercise for adults with fasting triglycerides over 500 mg/dL to help prevent pancreatitis.
How cholesterol test results are interpreted
Many lab reports show reference ranges, but cholesterol interpretation is not just a normal-versus-abnormal exercise. It is a risk assessment. A result that is acceptable for a young adult with low risk may not be the goal for someone with established cardiovascular disease. Conversely, a mildly abnormal value may lead first to lifestyle changes and repeat testing rather than immediate medication in a low-risk person.
| Result | General adult reference category often seen on lab reports | Important context |
|---|---|---|
| Total cholesterol | Less than 200 mg/dL is commonly considered desirable. | Total cholesterol alone does not show whether LDL, HDL or triglycerides are driving the result. |
| LDL-C | Less than 100 mg/dL is often listed as optimal for many adults. | Targets may be lower for people at higher cardiovascular risk; LDL-C of 190 mg/dL or higher raises concern for severe hypercholesterolemia. |
| HDL-C | Higher is generally better; low HDL is commonly flagged. | HDL is a risk marker, not usually the main medication target. |
| Triglycerides | Less than 150 mg/dL is commonly considered normal. | Very high triglycerides require prompt clinical follow-up because of pancreatitis risk. |
| Non-HDL-C | Often interpreted relative to LDL goals, typically about 30 mg/dL higher than the LDL-C goal. | Useful when triglycerides are elevated or when LDL-C may underestimate particle burden. |
The MedlinePlus overview of cholesterol levels provides commonly used categories, including triglycerides below 150 mg/dL as normal. These categories are helpful for understanding a lab report, but they should not be treated as individualized treatment goals.
When advanced cholesterol tests may be used
Advanced cholesterol tests are not needed for everyone, but they can be useful when a standard lipid panel leaves an important question unanswered. In 2026, the ACC/AHA multisociety dyslipidemia guideline replaced the 2018 cholesterol guideline and broadened risk assessment beyond LDL-C alone. The updated guidance highlights Lp(a) testing at least once in adulthood and selective ApoB measurement to refine risk assessment and guide treatment decisions.
Apolipoprotein B (ApoB)
ApoB is a protein carried on LDL, VLDL, IDL, Lp(a) and other atherogenic particles. Each of these particles typically carries one ApoB molecule, so ApoB can reflect the number of artery-plaque-forming particles rather than only the amount of cholesterol inside them. This can matter when LDL-C and particle number are discordant.
ApoB may be especially helpful when triglycerides are elevated, in type 2 diabetes, metabolic syndrome, obesity, chronic kidney disease, known cardiovascular disease or when LDL-C appears controlled but risk remains high. The 2026 ACC/AHA guideline publication describes ApoB measurement as reasonable in adults on lipid-lowering therapy, particularly those with ASCVD, cardiovascular-kidney-metabolic syndrome, type 2 diabetes or elevated triglycerides, when further treatment decisions are being considered after LDL-C or non-HDL-C goals are achieved.
Lipoprotein(a), or Lp(a)
Lp(a) is a genetically influenced particle that is not included in a standard lipid panel unless specifically ordered. Diet and routine lifestyle changes usually have limited effect on Lp(a) levels, but knowing the result can change how aggressively other modifiable risk factors are managed. The American College of Cardiology notes that the 2026 guideline includes Lp(a) and ApoB testing among key updates for managing dyslipidemia.
Lp(a) can be particularly relevant if you have a personal or family history of premature heart attack, stroke, aortic valve disease or very high LDL-C. Because Lp(a) is largely inherited, an abnormal result may also have implications for relatives, who can ask their own clinicians whether testing is appropriate.
Direct LDL-C, LDL particle testing and other specialized tests
Direct LDL-C may be ordered when triglycerides are high enough that calculated LDL-C is unreliable. Some clinicians use LDL particle number, remnant cholesterol or other advanced lipid markers in selected cases, but these tests are not first-line screening for most people. They should answer a specific clinical question; otherwise they can add cost and confusion without changing the plan.
How to prepare for a cholesterol blood test
Preparation depends on the exact test and the reason it is being ordered. Many routine lipid panels can be drawn without fasting, which makes screening easier. However, fasting may still be requested if your clinician is focused on triglycerides, if a previous nonfasting result was high, if you are being evaluated for an inherited lipid disorder, or if the lab or ordering clinician requires it. The CDC advises that some people may need to fast for 8 to 12 hours and should ask their doctor how to prepare.
- If fasting is required: water is usually allowed, but avoid food, alcohol and caloric drinks during the fasting window unless your clinician says otherwise.
- Take medicines as directed: do not stop prescribed medication just to improve a result unless the ordering clinician tells you to.
- Avoid unusual behavior right before testing: a heavy alcohol intake, unusually large meal or abrupt dietary change can distort triglycerides.
- Tell the clinician if you are pregnant, recently ill or recently hospitalized: these situations can affect lipid values and timing of testing.
- Bring prior results if possible: cholesterol trends are often more useful than one isolated number.
Cost and ordering considerations
Cholesterol testing is widely available through primary care offices, commercial laboratories, community screening programs and some at-home or point-of-care options. A standard lipid panel is usually less expensive than advanced tests such as ApoB or Lp(a), but the cost to the patient depends on insurance coverage, deductible status, the collection site, whether a clinician visit is required and whether separate order or draw fees apply.
| Ordering route | What to compare | Best fit |
|---|---|---|
| Clinician-ordered lab test | Insurance coverage, office visit cost, lab network status and follow-up access. | Best when results will guide diagnosis, medication or ongoing care. |
| Direct-to-consumer lab order | Advertised test price plus required clinician authorization, draw fee, processing fee and state availability. | May be useful for straightforward screening or follow-up if you can share results with your clinician. |
| Community screening or workplace screening | Whether the test is fasting or nonfasting, fingerstick or venous, and whether abnormal results include follow-up guidance. | Convenient screening, but abnormal results should be confirmed in a clinical setting. |
| Home cholesterol test | Which markers are measured, FDA status, sample type, instructions, accuracy information and whether results are lab-confirmed. | May help with awareness or tracking, but not ideal as the only basis for treatment decisions. |
If you are paying cash, compare the effective total cost rather than the headline price. Ask whether the price includes the lab test, specimen collection, clinician order, required consultation, platform fee and result review. If you have insurance, confirm that the lab is in network and that the diagnosis or preventive-screening code is covered.
For home testing, the U.S. Food and Drug Administration explains that home cholesterol tests may use a fingerstick blood sample and that accuracy can vary by brand. A home result that is high, inconsistent with prior results or being used to make treatment decisions should be discussed with a healthcare professional and often confirmed with a standard laboratory lipid panel.
What to do after abnormal cholesterol results
An abnormal lipid panel is not a diagnosis by itself. It is a signal to look at cardiovascular risk, possible secondary causes and practical next steps. Your clinician may repeat the test, calculate your 10-year and longer-term cardiovascular risk, review family history, check blood pressure, screen for diabetes, evaluate kidney or thyroid function, or discuss medication if your risk profile supports it.
Practical next steps often include:
- Confirm the result when needed. Repeat testing may be appropriate if the result is unexpected, nonfasting triglycerides are high or the sample was drawn during acute illness.
- Look for secondary causes. Diabetes, hypothyroidism, kidney disease, liver disease, pregnancy, alcohol intake and some medications can affect cholesterol or triglycerides.
- Assess inherited risk. Very high LDL-C, premature cardiovascular disease in close relatives or high Lp(a) may point toward inherited risk.
- Discuss lifestyle changes that match the result. A heart-healthy eating pattern, soluble fiber, replacing saturated fat with unsaturated fat, regular physical activity, weight management when appropriate and avoiding tobacco can improve risk.
- Consider medication when risk is high enough. Statins and other lipid-lowering medicines are used based on overall risk, not just one number.
- Plan follow-up testing. After starting or changing treatment, repeat lipid testing helps determine response and adherence.
The U.S. Preventive Services Task Force recommends statin therapy for certain adults ages 40 to 75 who have at least one cardiovascular risk factor and an estimated 10-year cardiovascular disease risk of 10% or greater, with selective use for some adults at lower estimated risk. This is one example of how cholesterol numbers are combined with other risk factors before treatment decisions are made.
FAQs
What blood test checks for high cholesterol?
The standard test is a lipid panel or lipid profile. It usually includes total cholesterol, LDL-C, HDL-C and triglycerides. Some reports also calculate non-HDL cholesterol.
Do I need to fast before a cholesterol test?
Not always. Many screening lipid panels can be nonfasting. Fasting is commonly requested when triglycerides are high, when a prior result needs confirmation, or when the clinician wants the most standardized comparison. If fasting is required, the usual window is 8 to 12 hours.
Is LDL the most important cholesterol number?
LDL-C is one of the most important numbers because it is a major treatment focus. Still, it is not interpreted alone. HDL-C, triglycerides, non-HDL-C, ApoB or Lp(a), plus age, blood pressure, smoking, diabetes, kidney disease and family history may all change the interpretation.
What is non-HDL cholesterol?
Non-HDL cholesterol equals total cholesterol minus HDL cholesterol. It represents cholesterol carried by LDL and other atherogenic particles. It can be especially useful when triglycerides are elevated.
Should everyone get ApoB?
No. ApoB can be useful in selected people, especially when triglycerides are high, diabetes or metabolic syndrome is present, cardiovascular disease is known, or LDL-C may underestimate particle-related risk. It is not required for every routine screening panel.
Should everyone get Lp(a)?
Current ACC/AHA dyslipidemia guidance supports measuring Lp(a) at least once in adulthood. It is especially important to ask about if you have a family history of premature heart disease or stroke, very high LDL-C or unexplained cardiovascular risk.
Can high cholesterol be diagnosed from one test?
Sometimes a single result is enough to identify a clearly abnormal pattern, but repeat testing is often used when results are borderline, unexpected or affected by recent meals or illness. Treatment decisions usually depend on the overall risk picture.
Can I order my own cholesterol test?
In many states, direct-to-consumer laboratory testing is available, but ordering rules and follow-up options vary. If you order your own test, compare total cost and share abnormal results with a qualified healthcare professional.
Sources
- CDC: Testing for Cholesterol
- MedlinePlus: Cholesterol Levels Test
- MedlinePlus: Cholesterol Levels — What You Need to Know
- American Heart Association: HDL, LDL and Triglycerides
- American Heart Association: 2026 Guideline on the Management of Dyslipidemia
- Circulation: 2026 ACC/AHA Multisociety Dyslipidemia Guideline
- Endocrine Society: Lipid Management Guideline
- FDA: Home-Use Cholesterol Tests
- USPSTF: Statin Use for Primary Prevention
